Afimmune
Dublin, IE · 1 known investors
Afimmune develops new medicines for rare and inflammatory diseases through drug discovery and development programs at various clinical and pre-clinical stages.
BiotechMedical Devices
Investors · 1
In the news
- Afimmune Deutschland GmbH - 2026 Company Profile - Tracxntracxn.com · 2025
- Association between COVID-19 outcomes and mask mandates, adherence, and attitudes | PLOS Onejournals.plos.org · 2021
- Investors - Afimmuneafimmune.com